Basic Information
PANBESY CAPSULE 15 MG
CAPSULE
Regulatory Information
SIN05315P
January 7, 1991
Prescription Only
Therapeutic
ORAL
August 10, 2023
June 3, 2025
XA08AA01
Company Information
EURO ASIA MEDICO PTE. LTD.
EURODRUG LABORATORIES SINGAPORE PTE. LTD.
Active Ingredients
PHENTERMINE HCl
Strength: 15 mg
Detailed Information
Contraindications
**CONTRAINDICATIONS** Epilepsy; hypersensitivity to sympathomimetic amines; advanced arteriosclerosis; severe hypertension; children under 12 years; hyperexcitability; patients with cardiovascular disease; hyperthyroidism; glaucoma. Patients with a history of drug abuse. During or 14 days following administration of monoamine oxidase inhibitors.
Indication Information
**INDICATIONS** For short term use as an adjunct to the treatment of some patients with moderate to severe obesity.